{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:14:51Z","timestamp":1788196491994,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100025250","name":"Vancouver Coastal Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025250","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008002","name":"Vancouver Coastal Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.contraception.2026.111487","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:19:38Z","timestamp":1779319178000},"page":"111487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Temporal trends in contraceptive use in British Columbia, Canada between 2001 and 2021: A descriptive analysis"],"prefix":"10.1016","volume":"162","author":[{"given":"Alice J.","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Shore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Abreu do Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste Leigh","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Meza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian E.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.contraception.2026.111487_bib1","first-page":"15","article-title":"Oral contraceptive use in Canada","volume":"36","author":"Rotermann","year":"2025","journal-title":"Health Rep"},{"key":"10.1016\/j.contraception.2026.111487_bib2","series-title":"StatPearls [Internet]","article-title":"Oral Contraceptive Pills","author":"Cooper","year":"2024"},{"issue":"10","key":"10.1016\/j.contraception.2026.111487_bib3","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S1701-2163(16)39370-7","article-title":"Canadian Contraception Consensus Chapter 1 Contraception in Canada","volume":"37","year":"2015","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.contraception.2026.111487_bib4","unstructured":"Summary Safety Review - Birth control hormone systems (intrauterine) - Assessing the potential risk of less breast milk production. [cited 2026 Jan 5]. Available from: \u3008https:\/\/dhpp.hpfb-dgpsa.ca\/review-documents\/resource\/SSR00177\u3009."},{"issue":"7","key":"10.1016\/j.contraception.2026.111487_bib5","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/pch\/pxab014","article-title":"What do I need to know about the etonogestrel-relesasing contraceptive implant (Nexplanon)?","volume":"26","author":"Rosenthal","year":"2021","journal-title":"Paediatr Child Health"},{"issue":"4","key":"10.1016\/j.contraception.2026.111487_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/pch\/pxx192","article-title":"Contraceptive care for Canadian youth","volume":"23","author":"Di Meglio","year":"2018","journal-title":"Paediatr Child Health"},{"issue":"10","key":"10.1016\/j.contraception.2026.111487_bib7","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1701-2163(16)30033-0","article-title":"Canadian contraception consensus (part 1 of 4)","volume":"37","author":"Black","year":"2015","journal-title":"J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC"},{"issue":"5","key":"10.1016\/j.contraception.2026.111487_bib8","first-page":"1173","article-title":"Summary: long-acting reversible contraception: implants and intrauterine devices","volume":"130","author":"Practice Bulletin No. 186","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2026.111487_bib9","unstructured":"Canada D of F. Government highlights next step to universal access to free contraceptives [news releases]. 2024 [cited 2024 Aug 20]. Available from: https:\/\/www.canada.ca\/en\/department-finance\/news\/2024\/03\/government-highlights-next-step-to-universal-access-to-free-contraceptives.html."},{"issue":"3","key":"10.1016\/j.contraception.2026.111487_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-0036-1571434","article-title":"Permanent contraception for women","volume":"34","author":"Patil","year":"2016","journal-title":"Semin Reprod Med"},{"issue":"3","key":"10.1016\/j.contraception.2026.111487_bib11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ajog.2020.09.011","article-title":"Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis","volume":"224","author":"Mills","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.contraception.2026.111487_bib12","article-title":"Committee opinion No. 774: opportunistic salpingectomy as a strategy for epithelial ovarian cancer prevention","volume":"133","author":"ACOG","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.contraception.2026.111487_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jogc.2016.12.005","article-title":"No. 344-Opportunistic salpingectomy and other methods of risk reduction for ovarian\/fallopian tube\/peritoneal cancer in the general population","volume":"39","author":"Salvador","year":"2017","journal-title":"J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC"},{"issue":"6","key":"10.1016\/j.contraception.2026.111487_bib14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ajog.2021.12.261","article-title":"Female permanent contraception trends and updates","volume":"226","author":"Fang","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2026.111487_bib15","doi-asserted-by":"crossref","first-page":"477.e1","DOI":"10.1016\/j.ajog.2022.05.021","article-title":"Update on incidence of inpatient tubal ligation and long-acting reversible contraception in the United States","volume":"227","author":"Fang","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.contraception.2026.111487_bib16","article-title":"Opportunistic salpingectomy between 2017 and 2020: a descriptive analysis","volume":"46","author":"Kaur","year":"2024","journal-title":"J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC"},{"issue":"1","key":"10.1016\/j.contraception.2026.111487_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/andr.13093","article-title":"Vasectomy utilization in men aged 18\u201345 declined between 2002 and 2017: results from the United States National Survey for Family Growth data","volume":"10","author":"Zhang","year":"2022","journal-title":"Andrology"},{"issue":"6","key":"10.1016\/j.contraception.2026.111487_bib18","first-page":"587","article-title":"Trends in oral contraceptive and intrauterine device use among reproductive-aged women in the US from 1999 to 2017","volume":"32","author":"King","year":"2021","journal-title":"Cancer Causes Control CCC"},{"issue":"1","key":"10.1016\/j.contraception.2026.111487_bib19","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3747\/co.26.4068","article-title":"Selected medical interventions in women with a deleterious BRCA mutation: a population-based study in British Columbia","volume":"26","author":"Hanley","year":"2019","journal-title":"Curr Oncol"},{"issue":"2","key":"10.1016\/j.contraception.2026.111487_bib20","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.46747\/cfp.7102e35","article-title":"Extended duration of use of long-acting reversible contraceptives","volume":"71","author":"Guilbert","year":"2025","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.contraception.2026.111487_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/OAJC.S82176","article-title":"Five-year review of copper T intrauterine device use at the University of Calabar Teaching Hospital, Calabar","volume":"6","author":"Iklaki","year":"2015","journal-title":"Open Access J Contracept"},{"issue":"2","key":"10.1016\/j.contraception.2026.111487_bib22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jogc.2015.12.002","article-title":"Canadian contraception consensus (part 3 of 4): chapter 7--intrauterine contraception","volume":"38","author":"Black","year":"2016","journal-title":"J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC"},{"issue":"5","key":"10.1016\/j.contraception.2026.111487_bib23","first-page":"1173","article-title":"Summary: long-acting reversible contraception: implants and intrauterine devices","volume":"130","author":"Practice Bulletin No. 186","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2026.111487_bib24","unstructured":"U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. [cited 2026 Jan 8]. Available from: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5904a1.htm."},{"key":"10.1016\/j.contraception.2026.111487_bib25","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.rr6503a1","article-title":"U.S. Medical Eligibility Criteria for Contraceptive Use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2026.111487_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2021.114247","article-title":"Reasons for rejecting hormonal contraception in Western countries: a systematic review","volume":"284","author":"Le Guen","year":"2021","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.contraception.2026.111487_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2023.116081","article-title":"Interrogating the pill: rising distrust and the reshaping of health risk perceptions in the social media age","volume":"331","author":"Schneider-Kamp","year":"2023","journal-title":"Soc Sci Med"},{"issue":"2","key":"10.1016\/j.contraception.2026.111487_bib28","doi-asserted-by":"crossref","first-page":"257.e1","DOI":"10.1016\/j.ajog.2022.04.036","article-title":"Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States","volume":"227","author":"Karia","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2026.111487_bib29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.AOG.0000459871.88564.09","article-title":"Committee opinion no. 620: salpingectomy for ovarian cancer prevention","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2026.111487_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.contraception.2021.12.002","article-title":"Impact of Coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France","volume":"108","author":"Roland","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2026.111487_bib31","article-title":"Impacts of British Columbia\u2019s free contraception policy on out-of-pocket payments and contraception costs: an interrupted time series analysis with other provinces as controls","author":"Nethery","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.contraception.2026.111487_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-083874","article-title":"Effect of universal no-cost coverage on use of long-acting reversible contraception and all prescription contraception: population based, controlled, interrupted time series analysis","volume":"390","author":"Schummers","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2026.111487_bib33","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.12688\/gatesopenres.13045.2","article-title":"Access to family planning for youth: perspectives of young family planning leaders from 40 countries","volume":"3","author":"Cartwright","year":"2019","journal-title":"Gates Open Res"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782426001241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782426001241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:34:25Z","timestamp":1788194065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782426001241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"alternative-id":["S0010782426001241"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2026.111487","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal trends in contraceptive use in British Columbia, Canada between 2001 and 2021: A descriptive analysis","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2026.111487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111487"}}